A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer
暂无分享,去创建一个
S. Cedrés | D. Planchard | K. Yoh | M. Nishio | N. Yamamoto | T. Morán | H. Hayashi | J. Dowell | H. Sakai | K. Benhadji | A. Cortot | V. Gregorc | L. Makris | Nital Soni | Jinhong Huang | S. Cedres